For the Inventor, By the Inventor

Enter assignee name

Santa Clara, CA, United States of America

Ancora Heart, Inc.

USPTO Granted Patents = 28

CIPO Patents = 25

EPO Patents = 15

Trademarks = 2

Forward Citations = 163

Loading Chart...

Loading Chart...

73 inventors (with patents filed for the assignee):

Russel Mahlon Sampson (10 out of 40 patents)

Mariel Fabro (8 out of 62 patents)

David Scott Baron (8 out of 8 patents)

4. Eugene Serina (8 out of 20 patents)

5. Huu Nguyen (7 out of 12 patents)

6. Charles J Adam (6 out of 18 patents)

7. Niel F Starksen (6 out of 27 patents)

8. Son Truong Nguyen (6 out of 53 patents)

9. Tammy Y Tam (5 out of 15 patents)

10. Rob Kotmel (5 out of 5 patents)

11. Jennifer Henderson (4 out of 4 patents)

12. John T To (4 out of 140 patents)

13. Tiffany Mirchandani (3 out of 3 patents)

14. Rodolfo A Morales (3 out of 13 patents)

15. Stephen Clark Meier (3 out of 5 patents)

28 patents: Sort by Forward Citations

1. 12465723 - Device and method for releasing catheters from cardiac structures (2025-11-11),

2. 12446872 - Devices and methods for tether cutting (2025-10-21),

3. 12257151 - Myocardial implant load sharing device and methods to promote LV function (2025-03-25),

4. 12102316 - Devices and methods of visualizing and determining depth of penetration in cardiac tissue (2024-10-01),

5. 12082813 - Multi-window guide tunnel (2024-09-10),

6. 11980722 - Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods (2024-05-14),

7. 11964112 - Device and method for releasing catheters from cardiac structures (2024-04-23),

8. 11672524 - Devices and methods for tether cutting (2023-06-13),

9. 11202883 - Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods (2021-12-21),

10. 10980973 - Device and method for releasing catheters from cardiac structures (2021-04-20),

11. 10980529 - Devices and methods of visualizing and determining depth of penetration in cardiac tissue (2021-04-20),

12. 10898328 - Devices and methods for heart valve repair (2021-01-26),

13. 10709449 - Systems and methods for variable stiffness tethers (2020-07-14),

14. 10667914 - Myocardial implant load sharing device and methods to promote LV function (2020-06-02),

15. 10625047 - Anchor deployment devices and related methods (2020-04-21),

Ancora Heart, Inc. is a medical technology company dedicated to developing innovative therapies to address heart failure. Their mission is to improve the quality of life for patients with advanced heart failure by providing minimally invasive treatment options. They focus on developing solutions that preserve and enhance heart function, ultimately aiming to reduce hospitalizations and improve overall outcomes for patients. Ancora Heart's expertise in cardiovascular devices, combined with their commitment to research and development, drives their mission to revolutionize heart failure treatment.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

28 Patents

#158 in Santa Clara, CA

#2,763 in California

#11,597 in US

#22,547 in the World

Santa Clara, CA, United States of America

Ancora Heart, Inc.

Forward Citations = 163

73 inventors:

Russel Mahlon Sampson (10 out of 40 patents)

Mariel Fabro (8 out of 62 patents)

David Scott Baron (8 out of 8 patents)

4. Eugene Serina (8 out of 20 patents)

5. Huu Nguyen (7 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…